Prudential Financial’s Black Diamond Therapeutics BDTX Stock Holding History

Prudential Financial’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.5K	Buy	17,150 +4,300	+33%	+$10.2K	﹤0.01%	2343
2025 Q4	$31.2K	Sell	12,850 -250	-2%	-$885	﹤0.01%	2177
2025 Q3	$49.6K	Hold	13,100	–	–	﹤0.01%	2335
2025 Q2	$32.5K	Buy	+13,100	New	+$25.2K	﹤0.01%	2371
2021 Q1	–	Sell	-37,490	Closed	-$1.2M	–	2492
2020 Q4	$1.2M	Buy	37,490 +16,350	+77%	+$537K	﹤0.01%	1664
2020 Q3	$639K	Buy	21,140 +180	+0.9%	+$5.48K	﹤0.01%	1860
2020 Q2	$883K	Buy	20,960 +50	+0.2%	+$1.84K	﹤0.01%	1703
2020 Q1	$522K	Buy	+20,910	New	+$636K	﹤0.01%	1898

Other funds holding BDTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Prudential Financial's BDTX Position: Q1 2026 in Review

Prudential Financial increased its Black Diamond Therapeutics (BDTX) stake by 33% in Q1 2026, buying an estimated $10.2K and bringing the position to 17,150 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

Prudential Financial first reported a position in BDTX in Q1 2020 and has held it in 8 quarters since. The position peaked at $1.2M in Q4 2020. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

Prudential Financial held 17,150 shares of Black Diamond Therapeutics worth $36.5K as of Q1 2026.
Prudential Financial bought 4,300 Black Diamond Therapeutics shares in Q1 2026, an estimated $10.2K.
Black Diamond Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2343 holding.
Prudential Financial first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 8 quarters since.
Prudential Financial's Black Diamond Therapeutics position peaked at $1.2M in Q4 2020.
104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.